Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
COYA
#3927
Coya Therapeutics, Inc. - Common Stock
4.9
7
USD
+0.02%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
+2.47%
Monthly Change
+3.97%
6 month change
+7.34%
Year Change
-18.92%
Previous Close
4.8
5
Open
4.9
0
Low
4.8
2
High
5.3
5
Volume
162
Markets
US Stock Market
Healthcare
Biotechnology
COYA
1W
1M
3M
6M
YTD
1Y
5Y
Open full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Value
2022
2023
2024
2025
Current
Key stats
Total common shares outstanding
9.95 M
14.54 M
16.72 M
23.46 M
23.46 M
Valuation ratios
Enterprise value
62.08 M
77.38 M
57.49 M
89.23 M
76.06 M
Price to earnings ratio
-0.98
-8.81
-5.85
-4.57
-4.7
Price to sales ratio
—
11.79
24.57
12.21
11.49
Price to cash flow ratio
-1.66
-6.32
-8.49
-9.04
-7.23
Price to book ratio
-0.7
2.64
2.21
2.26
0.67
Enterprise value to EBITDA ratio
—
-9.83
-3.34
-3.96
-3.38
Profitability ratios
Return on assets %
-1.46
-0.19
-0.34
-0.42
-0.14
Return on equity %
1.46
-0.22
-0.38
-0.49
-0.15
Return on invested capital %
-3 242.01
-1 216.1
-1 746.24
-7 463.01
-2 484.48
Gross margin %
—
100
100
100
100
Operating margin %
—
-131.67
-485.35
-283.87
-3 042.13
EBITDA margin %
—
-131.22
-484.58
-283.52
-3 041.01
Net margin %
—
-133.08
-418.7
-267.14
-2 869.63
Liquidity ratios
Quick ratio
—
—
—
—
—
Current ratio
1.88
8.15
11.59
8.5
15.02
Inventory turnover
—
—
—
—
—
Asset turnover
—
0.24
0.08
0.17
0
Solvency ratios
Debt to assets ratio
1.54
—
—
—
—
Debt to equity ratio
-1.54
—
—
—
—
Long term debt to total assets ratio
-0.13
—
—
—
—
Long term debt to total equity ratio
0.13
—
—
—
—
Per share metrics
Operating cash flow per share
-2.79
-1.1
-0.68
-0.64
-0.75
EBIT per share
—
-0.78
-1.13
-1.35
-1.23
EBITDA per share
—
-0.77
-1.13
-1.35
-1.23
Total debt per share
5.01
—
—
—
—
Cash per share
2.29
3.21
2.52
2.8
2.24
Net current asset value per share
2.77
4.05
2.91
2.98
2.35
Tangible book value per share
-6.64
2.64
2.6
2.57
2.16
Working capital per share
1.3
3.56
2.66
2.63
2.2
Book value per share
-6.64
2.64
2.6
2.57
2.16
News
Is Coya Therapeutics, Inc. (COYA) Stock Outpacing Its Medical Peers This Year?
3 Best Stocks to Buy Today, 3/23/2026, According to Top Analysts - TipRanks.com
Coya Therapeutics, Inc. (COYA) Upgraded to Buy: What Does It Mean for the Stock?
H.C. Wainwright reiterates Buy rating on Coya Therapeutics stock with $18 target
Coya Therapeutics secures $11.1 million in private placement
Coya Therapeutics advances ALS and FTD clinical trials in 2026
H.C. Wainwright reiterates Buy rating on Coya Therapeutics stock at $18
Tracking David Einhorn’s Greenlight Capital Portfolio – Q3 2025 Update (NYSE:GRBK)
H.C. Wainwright reiterates Buy rating on Coya Therapeutics stock
H.C. Wainwright reaffirms Buy rating on Coya Therapeutics stock at $18 target
Coya Therapeutics closes $23 million public offering of common stock
Coya Therapeutics stock falls after pricing $20 million public offering